Millennium Management
ABVC icon

Millennium Management’s ABVC BioPharma ABVC Stock Holding History

Millennium Management’s Portfolio ABVC Stock Details ABVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,603
Closed -$59.6K – 5951
2025
Q3 		$59.6K Buy
+19,603
New +$60.2K ﹤0.01% 5790
2022
Q4 		– Sell
-1,101
Closed -$10K – 6519
2022
Q3 		$10K Buy
+1,101
New +$9.26K ﹤0.01% 6650

Other funds holding ABVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's ABVC Position: Q4 2025 in Review

Millennium Management sold out of ABVC BioPharma (ABVC) in Q4 2025, closing a stake of 19,603 shares — an estimated $59.6K sold.

Millennium Management first reported a position in ABVC in Q3 2022 and held it in 2 quarters. The position peaked at $59.6K in Q3 2025. 14 funds tracked by Wall St. Rank hold ABVC as of Q4 2025.

  • Millennium Management reported no remaining ABVC BioPharma position as of Q4 2025 after selling out during the quarter.
  • Millennium Management sold 19,603 ABVC BioPharma shares in Q4 2025, an estimated $59.6K.
  • Millennium Management first reported a position in ABVC BioPharma in Q3 2022 and held it in 2 quarters.
  • Millennium Management's ABVC BioPharma position peaked at $59.6K in Q3 2025.
  • 14 funds tracked by Wall St. Rank held ABVC BioPharma as of Q4 2025.

Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.